Page last updated: 2024-11-01

niclosamide and Carcinoma, Pancreatic Ductal

niclosamide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kang, HW1
Kim, JH1
Lee, DE1
Lee, YS1
Kim, MJ1
Kim, HS1
Fang, S1
Lee, BE1
Lee, KJ1
Yoo, J1
Kim, HJ1
Park, JS1

Other Studies

1 other study available for niclosamide and Carcinoma, Pancreatic Ductal

ArticleYear
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.
    Cancer biology & therapy, 2023, 12-31, Volume: 24, Issue:1

    Topics: Apoptosis; beta Catenin; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gemcita

2023